Resistance to therapy in mature palmerston north mice treated with cyclophosphamide or hydrocortisone sodium succinate
- 1 May 1980
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 23 (5) , 539-544
- https://doi.org/10.1002/art.1780230504
Abstract
Inbred Palmerston North (PN) mice are a newly reconized model of systemic lupus erythematosus.In this study PN mice with established autoimmune disease were treated until death with cyclophosphamide (8 mg/kg/day) or hydrocortisone (10 mg/kg/day). These doses had previously been found to prevent or suppress disease in another lupus model, the NZB/NZW mouse. In the PN strain, autoantibodies, severity of glomerulo‐nephritis, and longevity were not influenced by treatment. Furthermore, the incidence of neoplasms was not increased in PN mice receiving prolonged therapy with immunosuppressive drugs. Unlike NZB/NZW mice, PN mice were resistant to the effects of cyclophomide and hydrocortisone.This publication has 8 references indexed in Scilit:
- Prolonged lifespan and high incidence of neoplasms in NZB/NZW mice treated with hydrocortisone sodium succinateKidney International, 1978
- Genetics of expression of xenotropic virus and autoimmunity in NZB miceNature, 1976
- Selective suppression of autoantibody responses in NZB/NZW MICE treated with long‐term cyclophosphamideArthritis & Rheumatism, 1975
- Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW MICEArthritis & Rheumatism, 1975
- Autoimmunity and Neoplasia: The Possible Role of C-type VirusesAmerican Journal of Clinical Pathology, 1974
- Therapeutic studies in NZB/W mice. II. Relative efficacy of azathioprine, cyclophosphamide and methylprednisoloneArthritis & Rheumatism, 1972
- CYCLOPHOSPHAMIDE TREATMENT OF RENAL DISEASE IN (NZB × NZW) F1 HYBRID MICEThe Lancet, 1968
- The Immunology and Pathology of NZB MicePublished by Elsevier ,1968